A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment

Capabilities
Authors: Alessia Balestrini, Victory Joseph, Michelle Dourado, Rebecca M. Reese, Shannon D. Shields, Lionel Rougé, Daniel D. Bravo, Tania Chernov-Rogan, Cary D. Austin, Huifen Chen, Lan Wang, Elisia Villemure, Daniel G. M. Shore, Vishal A. Verma, Baihua Hu, Yong Chen, Laurie Leong, Chris Bjornson, Kathy Hötzel, Alvin Gogineni, Wyne P. Lee, Eric Suto, Xiumin Wu, John Liu, Juan Zhang, Vineela Gandham, Jianyong Wang, Jian Payandeh, Claudio Ciferri, Alberto Estevez, Christopher P. Arthur, Jens Kortmann, Ryan L. Wong, Jose E. Heredia, Jonas Doerr, Min Jung, Jason A. Vander Heiden, Merone Roose-Girma, Lucinda Tam, Kai H Barck, Richard A. D. Carano, Han Ting Ding, Bobby Brillantes, Christine Tam, Xiaoying Yang, Simon S. Gao, Justin Q. Ly, Liling Liu, Liuxi Chen, Bianca M Liederer, Joseph H. Lin, Steven Magnuson, Jun Chen, David H. Hackos, Justin Elstrott, Alexis Rohou, Brian S. Safina, Matthew Volgraf, Rebecca N. Bauer, Lorena Riol-Blanco
J Exp Med. 2021 Apr 5;218(4):e20201637
DOI: 10.1084/jem.20201637
Access the publication at: https://pubmed.ncbi.nlm.nih.gov/33620419/